Younossi, Zobair M.
Karrar, Azza
Pierobon, Mariaelena
Birerdinc, Aybike
Stepanova, Maria
Abdelatif, Dinan
Younoszai, Zahra
Jeffers, Thomas
Felix, Sean
Jeiran, Kianoush
Hodge, Alex
Zhou, Weidong
Monge, Fanny
Alaparthi, Lakshmi
Chandhoke, Vikas
Goodman, Zachary D.
Petricoin, Emanuel F.
Article History
Received: 16 April 2018
Accepted: 23 July 2018
First Online: 12 September 2018
Ethics approval and consent to participate
: This study is designed as a part of the Translational Research in Chronic Disease (Younossi Protocol IRB Study #15–1842 (05.047), Version 22.0, dated April 11, 2017) ongoing at ‘The Beatty Liver and Obesity Research Program’ at the Center for Integrated Research, 3rd Floor, Claude Moore Health, Education, and Research Building. All the samples and biological materials used in this study were previously obtained from patients who were willing to participate in a research study and who provided their informed consent and HIPPA Authorization Form. The consent procedure was approved by the IRB and is described in detail in Younossi Protocol IRB Study #15–1842 (05.047), Version 22.0, dated April 11, 2017. The inclusion criteria specified adults, 18 years and older, who were willing to participate in the study and provide informed consent. The exclusion criteria for patients participating in the study were children under the age of 18 years, pregnant women, and patients who are not capable of providing consent.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.